Bederra acquires Diagnos for 15M common shares of stock
Bederra has acquired Diagnos in an all-stock transaction, in which Bederra issued 15 million restricted common shares of stock for the assets of Diagnos.

Diagnos will operate as a wholly owned subsidiary of Bederra, the Houston-based Bederra said. The financial statements issued by the company will reflect the combined financial results.

Diagnosis was formed to provide medical diagnostic imaging services utilizing PET technology to detect cancer, Alzheimer’s, dementia and heart disease.

Graham Williams, president of Bederra, said that the acquisition “is the first of many medical related acquisitions planned to enhance our revenues in the coming years.”